Kaufmann Gunnar F. 4
4 · Oncternal Therapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 4
Kaufmann Gunnar F.
Chief Scientific Officer
Transactions
- Award
Stock Option
2021-02-11+253,000→ 253,000 totalExercise: $7.05Exp: 2031-02-11→ Common Stock (253,000 underlying)
Footnotes (1)
- [F1]One-fourth (1/4th) of the shares subject to the stock options shall vest on first anniversary of the date of grant, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments over the three-year period thereafter, subject to the Reporting Person's continued employment or service with the Issuer on each such date.